Post operative pain management
Phase 2
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/04/041932
- Lead Sponsor
- Rajendra Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients posted for toal abdominal hysterectomy having ASA grade 1 and 2
Exclusion Criteria
Not willing to participate, ASA grade 3 or more,allergic to drug used,
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the analgesic effect of dexmedetomidine (0.5mcg/kg) added to 20 ml of 0.25% levobupivacaine on each side in TAP block in patients undergoing total abdominal hysterectomyTimepoint: At 2 hrs,4 hrs,6hrs,8hrs,12hrs and 24hrs
- Secondary Outcome Measures
Name Time Method To study changes in serum cortisol levels( pre and post op) after giving TAP blockTimepoint: Preop cortisol-1 day before <br/ ><br>Postop cortisol- after 12 hrs of surgical incision